 |
|
Treatment and outcomes: medical and surgical treatment for intestinal Behçet's disease
Tadakazu Hisamatsu, Mari Hayashida
Intest Res. 2017;15(3):318-327. Published online 2017 Jun 12 DOI: https://doi.org/10.5217/ir.2017.15.3.318
|
|
Citations to this article as recorded by
 Impact of age at diagnosis on long‐term prognosis in patients with intestinal Behçet's disease
Ji Young Chang, Soo Jung Park, Jae Jun Park, Tae Il Kim, Jae Hee Cheon, Jihye Park
Journal of Gastroenterology and Hepatology.2024; 39(3): 519. CrossRef Behçet's syndrome
Giacomo Emmi, Alessandra Bettiol, Gülen Hatemi, Domenico Prisco
The Lancet.2024; 403(10431): 1093. CrossRef Neither hepatic steatosis nor fibrosis is associated with clinical outcomes in patients with intestinal Behçet’s disease
Hye Kyung Hyun, Jihye Park, Soo Jung Park, Jae Jun Park, Tae Il Kim, Jae Seung Lee, Hye Won Lee, Beom Kyung Kim, Jun Yong Park, Do Young Kim, Sang Hoon Ahn, Seung Up Kim, Jae Hee Cheon
European Journal of Gastroenterology & Hepatology.2024; 36(4): 445. CrossRef Optimal Treatment Approaches to Intestinal Behçet's Disease Complicated by Myelodysplastic Syndrome: The KASID and KSBD Multicenter Study
Jung-Bin Park, So Jung Han, Seung Bum Lee, Dong Hyun Kim, Jae Hee Cheon, Sung Wook Hwang, Byong Duk Ye, Suk-Kyun Yang, Soo Jung Park, Sang Hyoung Park
Yonsei Medical Journal.2024; 65(5): 265. CrossRef Risk Factors for Surgery in Patients with Intestinal Behçet’s Disease During Anti-Tumor Necrosis Factor-Alpha Therapy
So Jung Han, Eun Ae Kang, Jihye Park, Soo Jung Park, Jae Jun Park, Tae Il Kim, Won Ho Kim, Jae Hee Cheon
Yonsei Medical Journal.2023; 64(2): 111. CrossRef Possible Association of Mutations in the MEFV Gene with the Intestinal Phenotype of Behçet’s Disease and Refractoriness to Treatment
Yoki Furuta, Ryosuke Gushima, Hideaki Naoe, Munenori Honda, Yuiko Tsuruta, Katsuya Nagaoka, Takehisa Watanabe, Masakuni Tateyama, Nahoko Fujimoto, Shinya Hirata, Eiko Miyagawa, Komei Sakata, Yumiko Mizuhashi, Mikako Iwakura, Masayuki Murai, Masao Matsuoka
Journal of Clinical Medicine.2023; 12(9): 3131. CrossRef Immune‐mediated inflammatory diseases of the gastrointestinal tract: Beyond Crohn's disease and ulcerative colitis
Sudheer K Vuyyuru, Saurabh Kedia, Pabitra Sahu, Vineet Ahuja
JGH Open.2022; 6(2): 100. CrossRef Mucosal healing in intestinal Behçet's disease: A systematic review and meta‐analysis
Liang Gong, Yue Lun Zhang, Lu Xi Sun, Guo Rong Chen, Dong Wu
Journal of Digestive Diseases.2021; 22(2): 83. CrossRef Experimental Therapeutic Solutions for Behcet’s Disease
Burçin Cansu Bozca, Erkan Alpsoy
Journal of Experimental Pharmacology.2021; Volume 13: 127. CrossRef Treatment of Behçet's Disease: An Algorithmic Multidisciplinary Approach
Erkan Alpsoy, Pietro Leccese, Giacomo Emmi, Shigeaki Ohno
Frontiers in Medicine.2021;[Epub] CrossRef Behçet Disease: An Update for Dermatologists
Erkan Alpsoy, Burcin Cansu Bozca, Asli Bilgic
American Journal of Clinical Dermatology.2021; 22(4): 477. CrossRef Long-term safety and effectiveness of adalimumab in 462 patients with intestinal Behçet’s disease: results from a large real-world observational study
Yasuo Suzuki, Takashi Hagiwara, Mariko Kobayashi, Kazuo Morita, Tomoyo Shimamoto, Toshifumi Hibi
Intestinal Research.2021; 19(3): 301. CrossRef Is fasting beneficial for hospitalized patients with inflammatory bowel diseases?
Yong Eun Park, Yehyun Park, Soo Jung Park, Tae Il Kim, Won Ho Kim, Jung Nam Kim, Na Rae Lee, Jae Hee Cheon
Intestinal Research.2020; 18(1): 85. CrossRef Elevated fecal calprotectin and lactoferrin associated with small intestinal lesions in patients with Behçet disease
Mari Hayashida, Jun Miyoshi, Tatsuya Mitsui, Miki Miura, Daisuke Saito, Akihito Sakuraba, Soko Kawashima, Noriko Ikegaya, Kazuhito Fukuoka, Miho Karube, Yoshinori Komagata, Shinya Kaname, Annabelle A Okada, Shunji Fujimori, Minoru Matsuura, Tadakazu Hisam
Journal of Gastroenterology and Hepatology.2020; 35(8): 1340. CrossRef Successful combination therapy using adalimumab and 5-aminosalicylic acid for a resistant case of intestinal Behçet’s disease
H. J. Kim, K.‑t. Kim, S.-G. Lee, Y. Kim
Zeitschrift für Rheumatologie.2020; 79(7): 702. CrossRef Update on the treatment of Behçet’s syndrome
Sinem Nihal Esatoglu, Gulen Hatemi
Internal and Emergency Medicine.2019; 14(5): 661. CrossRef Behсet's disease: intestinal damage
R. G. Goloeva, Z. S. Alekberova
Rheumatology Science and Practice.2019; 56(6): 767. CrossRef Intestinal manifestations of Behçet's disease
R G Goloeva, Z S Alekberova, T A Lisitsyna, E A Stepanova, L P Orlova
Terapevticheskii arkhiv.2019; 91(5): 111. CrossRef The outcomes and risk factors of early readmission in patients with intestinal Behçet’s disease
Yong Eun Park, Jae Hee Cheon, Yehyun Park, Soo Jung Park, Tae Il Kim, Won Ho Kim
Clinical Rheumatology.2018; 37(7): 1913. CrossRef Cancer Risk in Patients with Intestinal Behçet’s Disease: A Nationwide Population-Based Study
Minkyung Han, Yoon Suk Jung, Won Ho Kim, Jae Hee Cheon, Sohee Park
Gut and Liver.2018; 12(4): 433. CrossRef Updated treatment strategies for intestinal Behçet’s disease
Yong Eun Park, Jae Hee Cheon
The Korean Journal of Internal Medicine.2018; 33(1): 1. CrossRef Small Bowel Lesions Mimicking Crohn’s Disease
David B. Sachar
Current Gastroenterology Reports.2018;[Epub] CrossRef Anti-Tumor Necrosis Factor Therapy in Intestinal Beh Ccedil;et rsquo;s Disease
Jihye Park, Jae Hee Cheon
Gut and Liver.2018; 12(6): 623. CrossRef
|